Aura Biosciences (AURA) Tax Provisions (2023 - 2026)
Aura Biosciences' (AURA) quarterly Tax Provisions came in at $11000.0 in Q1 2026, down 38.89% YoY from $18000.0 in Q1 2025, and down 99.35% on a QoQ basis from $1.7 million in Q4 2025.
Analysis
Aura Biosciences (AURA) Tax Provisions (2023 - 2026) Analysis & Trends
Aura Biosciences (AURA) has 4 years of Tax Provisions data on file, last reported at $11000.0 in Q1 2026.
- Quarterly Tax Provisions fell 38.89% year-over-year to $11000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.8 million (up 53.14% YoY) and the FY2025 annual result came in at $1.8 million, up 50.84% from the prior year.
- Tax Provisions declined to $11000.0 in Q1 2026, from $1.7 million in the prior quarter.
- In the past five years, Tax Provisions ranged from a high of $1.7 million in Q4 2025 to a low of $4000.0 in Q2 2024.
- A 4-year average of $312200.0 and a median of $44500.0 in 2024 frame the typical range for Tax Provisions.
- The widest YoY moves for Tax Provisions: up 1100.0% in 2025, down 60.87% in 2025.
- Tracing AURA's Tax Provisions over 4 years: stood at $137000.0 in 2023, then jumped by 700.0% to $1.1 million in 2024, then jumped by 54.47% to $1.7 million in 2025, then slumped by 99.35% to $11000.0 in 2026.
- The last three Tax Provisions figures came in at $11000.0 (Q1 2026), $1.7 million (Q4 2025), and $26000.0 (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.78 Bn | 130.92 Bn | 2.84 Bn | 292.00 Mn |
| 2 | Regeneron Pharmaceuticals | 85.50 Bn | 77.51 Bn | 3.93 Bn | 230.90 Mn |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | -59.00 Mn |
| 4 | Moderna | 58.06 Bn | 52.92 Bn | 52.00 Mn | 15.00 Mn |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - | - |
| 6 | BeOne Medicines | 40.04 Bn | 34.94 Bn | 1.53 Bn | 75.45 Mn |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn | 13.31 Mn |
| 8 | Royalty Pharma | 28.41 Bn | 27.57 Bn | - | - |
| 9 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn | 1.90 Mn |
| 10 | Aura Biosciences | 711.48 Mn | 643.64 Mn | - | 29,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 29,000.00 |
| Mar 31, 2026 | 11,000.00 |
| Dec 31, 2025 | -22.38 Mn |
| Sep 30, 2025 | 26,000.00 |
| Jun 30, 2025 | 48,000.00 |
| Mar 31, 2025 | 20,000.00 |
| Dec 31, 2024 | -18.33 Mn |
| Sep 30, 2024 | 43,000.00 |
| Mar 31, 2024 | 50,000.00 |
| Dec 31, 2023 | 137,000.00 |